Leclercia adecarboxylata-Associated Catheter-Related Bloodstream Infection in a Hemodialysis Patient: A Case Report and Literature Review
Abstract
Leclercia adecarboxylata (L. adecarboxylata) is a motile, gram-negative bacillus from the Enterobacteriaceae family, traditionally considered a low-virulence environmental organism and gut commensal. However, increasing reports have pointed to its emerging role as an opportunistic pathogen capable of causing clinically significant infections in both immunocompromised and immunocompetent individuals. We describe a case of catheter-related bloodstream infection (CRBSI) in a 49-year-old female with end-stage renal disease on maintenance hemodialysis via a tunneled central venous catheter. She presented with persistent fever, myalgia, and elevated inflammatory markers. Paired blood cultures from the catheter and peripheral vein flagged positive within 24 hours, with earlier positivity in the catheter sample, suggesting CRBSI. Pure growth of gram-negative bacilli was identified as L. adecarboxylata using VITEK®2 and later re-confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial susceptibility testing demonstrated broad susceptibility except to select cephalosporins. The patient was successfully treated with intravenous meropenem and gentamicin lock therapy, resulting in complete clinical resolution. This case highlights the emerging clinical importance of L. adecarboxylata as a cause of CRBSI in hemodialysis patients. Accurate identification and prompt, targeted treatment are crucial for the best outcomes. It also…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.